東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Product liability litigation: An iss...

Rotthoff, Kurt W.

FindBook

Google Book

Amazon

博客來

Product liability litigation: An issue of Merck and lawsuits over Vioxx.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Product liability litigation: An issue of Merck and lawsuits over Vioxx./
作者:	Rotthoff, Kurt W.
面頁冊數:	108 p.
附註:	Adviser: Michael Maloney.
Contained By:	Dissertation Abstracts International68-03A.
標題:	Economics, Finance. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3256173

Product liability litigation: An issue of Merck and lawsuits over Vioxx.
Rotthoff, Kurt W.

Product liability litigation: An issue of Merck and lawsuits over Vioxx. - 108 p.

Adviser: Michael Maloney.

Thesis (Ph.D.)--Clemson University, 2007.

Merck & Co., Inc. pulled Vioxx, a Subjects--Topical Terms:

626650
Economics, Finance.

Product liability litigation: An issue of Merck and lawsuits over Vioxx.
LDR:01609nam 2200277 a 45 001 974400
005 20110929
008 110929s2007 eng d
035 $a (UMI)AAI3256173
035 $a AAI3256173
040 $a UMI $c UMI
100 1 $a Rotthoff, Kurt W. $3 1298334
245 1 0 $a Product liability litigation: An issue of Merck and lawsuits over Vioxx.
300 $a 108 p.
500 $a Adviser: Michael Maloney.
500 $a Source: Dissertation Abstracts International, Volume: 68-03, Section: A, page: 1107.
502 $a Thesis (Ph.D.)--Clemson University, 2007.
520 $a Merck & Co., Inc. pulled Vioxx, a $2 .5 billion a year nonsteroidal anti-inflammatory drug, off the shelf in September 2004. The removal followed a study that was published reporting Vioxx increased the risk of cardiovascular events after long-term use. In the years since then, many lawsuits have been filed against Merck. This paper examines the incentive to recall a product and the effects of Merck pulling Vioxx from the shelves. Using the market's expected internal rate of return for Merck, I calculate the expected profits from future Vioxx sales. I then use data on financial effects, along with the outcomes of cases already heard, to show how the market value of Merck reflects their probability of winning legal cases concerning Vioxx.
590 $a School code: 0050.
650 4 $a Economics, Finance. $3 626650
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Law. $3 600858
690 $a 0398
690 $a 0508
690 $a 0572
710 2 0 $a Clemson University. $3 997173
773 0 $t Dissertation Abstracts International $g 68-03A.
790 $a 0050
790 1 0 $a Maloney, Michael, $e advisor
791 $a Ph.D.
792 $a 2007
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3256173